These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23558289)

  • 1. Identification and functional characterization of novel MATE1 genetic variations in Koreans.
    Kim TH; Kim KH; Park HJ; Kim S; Choi JH
    Biochem Biophys Res Commun; 2013 May; 434(2):334-40. PubMed ID: 23558289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1.
    Ha Choi J; Wah Yee S; Kim MJ; Nguyen L; Ho Lee J; Kang JO; Hesselson S; Castro RA; Stryke D; Johns SJ; Kwok PY; Ferrin TE; Goo Lee M; Black BL; Ahituv N; Giacomini KM
    Pharmacogenet Genomics; 2009 Oct; 19(10):770-80. PubMed ID: 19745787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
    Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1.
    Kajiwara M; Terada T; Asaka J; Ogasawara K; Katsura T; Ogawa O; Fukatsu A; Doi T; Inui K
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1564-70. PubMed ID: 17855482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of genetic variations in the MDR3 promoter.
    Jang GH; Kim TH; Choe Y; Ham A; Choi JH
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1312-8. PubMed ID: 23261441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics.
    Chung JY; Cho SK; Kim TH; Kim KH; Jang GH; Kim CO; Park EM; Cho JY; Jang IJ; Choi JH
    Pharmacogenet Genomics; 2013 Jul; 23(7):365-73. PubMed ID: 23652408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between DNA Methylation in the 5' CpG Island of the
    Tanaka T; Hirota T; Ieiri I
    Mol Pharmacol; 2018 Jan; 93(1):1-7. PubMed ID: 29070695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment.
    Cho SK; Chung JY
    Int J Clin Pharmacol Ther; 2016 Apr; 54(4):253-62. PubMed ID: 26784938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of genetic polymorphisms of multidrug and toxin extrusion protein 1 on its mRNA expression in peripheral blood cells.
    Ando H; Nakano K; Ushijima K; Kurokawa S; Washino S; Hosohata K; Morita T; Fujimura A
    J Pharmacol Sci; 2016 Jun; 131(2):138-40. PubMed ID: 27025966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans.
    Kwon EY; Chung JY; Park HJ; Kim BM; Kim M; Choi JH
    Sci Rep; 2018 Nov; 8(1):16965. PubMed ID: 30446679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the Basal promoter element of human organic cation transporter 2 gene.
    Asaka J; Terada T; Ogasawara K; Katsura T; Inui K
    J Pharmacol Exp Ther; 2007 May; 321(2):684-9. PubMed ID: 17314196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic expression of HOXB4 is regulated in normal and leukemic stem cells through transcriptional activation of the HOXB4 promoter by upstream stimulating factor (USF)-1 and USF-2.
    Giannola DM; Shlomchik WD; Jegathesan M; Liebowitz D; Abrams CS; Kadesch T; Dancis A; Emerson SG
    J Exp Med; 2000 Nov; 192(10):1479-90. PubMed ID: 11085749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of OCTN2 variants and their association with phenotypes of Crohn's disease in a Korean population.
    Park HJ; Jung ES; Kong KA; Park EM; Cheon JH; Choi JH
    Sci Rep; 2016 Mar; 6():22887. PubMed ID: 26965072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09).
    Joerger M; van Schaik RH; Becker ML; Hayoz S; Pollak M; Cathomas R; Winterhalder R; Gillessen S; Rothermundt C
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):167-72. PubMed ID: 25753371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis.
    Toyama K; Yonezawa A; Masuda S; Osawa R; Hosokawa M; Fujimoto S; Inagaki N; Inui K; Katsura T
    Br J Pharmacol; 2012 Jun; 166(3):1183-91. PubMed ID: 22242910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.
    Stocker SL; Morrissey KM; Yee SW; Castro RA; Xu L; Dahlin A; Ramirez AH; Roden DM; Wilke RA; McCarty CA; Davis RL; Brett CM; Giacomini KM
    Clin Pharmacol Ther; 2013 Feb; 93(2):186-94. PubMed ID: 23267855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.
    Choi JH; Yee SW; Ramirez AH; Morrissey KM; Jang GH; Joski PJ; Mefford JA; Hesselson SE; Schlessinger A; Jenkins G; Castro RA; Johns SJ; Stryke D; Sali A; Ferrin TE; Witte JS; Kwok PY; Roden DM; Wilke RA; McCarty CA; Davis RL; Giacomini KM
    Clin Pharmacol Ther; 2011 Nov; 90(5):674-84. PubMed ID: 21956618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin.
    Paquette J; Bessette B; Ledru E; Deal C
    Endocrinology; 2007 Dec; 148(12):6007-18. PubMed ID: 17823260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease.
    Zhu W; Shiojima I; Hiroi Y; Zou Y; Akazawa H; Mizukami M; Toko H; Yazaki Y; Nagai R; Komuro I
    J Biol Chem; 2000 Nov; 275(45):35291-6. PubMed ID: 10948187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
    Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
    Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.